The women's health initiative postmenopausal hormone trials: overview and baseline characteristics of participants (Q79202505)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14575940%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

The Women's Health Initiative postmenopausal hormone trials: overview and baseline characteristics of participants (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14575940%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

The women's health initiative postmenopausal hormone trials: overview and baseline characteristics of participants (English)

1 reference

https://api.crossref.org/works/10.1016/S1047-2797(03)00045-0

24 March 2024

1

Marcia L Stefanick

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14575940%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Judith Hsia

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14575940%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Barbara B. Cochrane

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14575940

24 March 2024

David H. Barad

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14575940

24 March 2024

James H. Liu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14575940

24 March 2024

Susan R. Johnson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14575940

24 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14575940

24 March 2024

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14575940%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

20 December 2019

https://api.elsevier.com/content/article/PII:S1047279703000450?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1047-2797(03)00045-0

https://api.elsevier.com/content/article/PII:S1047279703000450?httpAccept=text/plain

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1047-2797(03)00045-0

24 March 2024

published in

Annals of Epidemiology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14575940%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14575940%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

9 Suppl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14575940%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

S78-86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14575940%20AND%20SRC:MED&resulttype=core&format=json

Design of the Women’s Health Initiative Clinical Trial and Observational Study

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2803%2900045-0

7 January 2021

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2803%2900045-0

7 January 2021

Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2803%2900045-0

7 January 2021

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2803%2900045-0

7 January 2021

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2803%2900045-0

7 January 2021

Effects of estrogen replacement on the progression of coronary-artery atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2803%2900045-0

7 January 2021

A clinical trial of estrogen-replacement therapy after ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2803%2900045-0

7 January 2021

Individualizing therapy to prevent long-term consequences of estrogen deficiency in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2803%2900045-0

7 January 2021

Epidemiology of hysterectomy in the United States: demographic and reproductive factors in a nationally representative sample

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2803%2900045-0

7 January 2021

Overview of women's decision making regarding elective hysterectomy, oophorectomy, and hormone replacement therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2803%2900045-0

7 January 2021

Population awareness and control of hypertension and hypercholesterolemia. The Atherosclerosis Risk in Communities study

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2803%2900045-0

7 January 2021

Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2803%2900045-0

7 January 2021

Menopause and the risk of coronary heart disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2803%2900045-0

7 January 2021

Hysterectomy, oophorectomy, and heart disease risk factors in older women

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2803%2900045-0

7 January 2021

Baseline characteristics of the PEPI participants. Postmenopausal Estrogen/Progestin Interventions.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2803%2900045-0

7 January 2021

Heart and Estrogen/progestin Replacement Study (HERS): design, methods, and baseline characteristics.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2803%2900045-0

7 January 2021

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14575940%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference